ClinicalTrials.gg
Active, not recruitingNCT07498166Updated Apr 1, 2026

Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair

An interventional study of Blood Flow Restriction Resistance Training (BFR-RT) and Sham Blood Flow Restriction in Achilles Tendon Rupture, Blood Flow Restriction Therapy and Achilles Tendon Repairs/Reconstructions, sponsored by Massachusetts General Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-01.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 23 studies in Tendon Injuries with a site in United States — 4 open to participants now, 7 under way, none of them phase 3. Tendon Injuries · United States.

Planned enrollment
5th of 18
75 · median 28
Started
2026
with 1 other
No phase
13 of 23
2 open now
Registered
23rd of 23
by date
Lead sponsor
1 of 23
Massachusetts General Hospital

Among the 23 studies in Tendon Injuries with a site in United States, this one is the 5th largest by planned enrollment of the 18 interventional ones that give a count, is one of 2 that started in 2026, is one of 13 with no phase, and was the 23rd registered.

Tendon Injuries

101 studies on the registry are indexed under Tendon Injuries; 28 are open to participants now.

Browse Tendon Injuries studies →

Open to participants now

4 of the 23 studies in Tendon Injuries with a site in United States are open now. Recruiting first, the newest first:

All 4 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 12 Tendon Injuries studies recruiting now, 5 (42%) set no upper age limit and 7 (58%) stop at 75 or younger; 3 take children under 18; 2 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 23 studies in Tendon Injuries with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to determine whether blood flow restriction resistance training (BFR-RT) improves postoperative muscle recovery and functional outcomes following primary surgical repair of acute Achilles tendon rupture (ATR) in adults undergoing standard rehabilitation. The main questions it aims to answer are:

Does patient-specific BFR-RT improve ankle plantarflexion strength recovery compared with sham BFR-RT or standard rehabilitation alone?

Does BFR-RT improve gastrocnemius-soleus muscle morphology and patient-reported functional outcomes following ATR repair?

Researchers will compare (1) BFR-RT combined with standard physical therapy, (2) sham BFR-RT combined with standard physical therapy, and (3) standard physical therapy alone to determine whether BFR-RT enhances muscle recovery, functional outcomes, and return-to-activity timelines following surgical ATR repair.

Participants will:

Be randomized to BFR-RT + standard physical therapy, sham BFR-RT + standard physical therapy, or standard physical therapy alone

Perform supervised rehabilitation exercises using a personalized tourniquet system calibrated to limb occlusion pressure (LOP) depending on group allocation

Undergo isometric ankle plantarflexion strength testing using the Fysiometer platform

Receive ultrasound imaging of the gastrocnemius-soleus complex to assess muscle cross-sectional area

Complete patient-reported outcome measures assessing pain and physical function

Attend follow-up evaluations at 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

Read the detailed description

Achilles tendon rupture (ATR) is a common musculoskeletal injury that frequently results in prolonged functional impairment despite successful surgical repair. Even with modern operative techniques and standardized rehabilitation protocols, many patients demonstrate persistent weakness of the gastrocnemius-soleus complex, deficits in ankle plantarflexion strength, and delayed return to activity. These deficits are thought to arise from a combination of postoperative immobilization, restricted early loading, and muscle atrophy during the early phases of recovery. Conventional postoperative rehabilitation protocols typically emphasize gradual progression of low-load resistance training to protect the healing tendon. While these protocols prioritize tendon safety, they may provide insufficient mechanical and metabolic stimulus to promote optimal muscle hypertrophy and neuromuscular recovery during the early postoperative period.

Blood flow restriction resistance training (BFR-RT) has emerged as a potential strategy to enhance muscular adaptation while using low mechanical loads. By applying controlled external pressure to the proximal limb during exercise, BFR-RT produces localized hypoxia and metabolic stress that can stimulate anabolic signaling pathways associated with muscle hypertrophy and strength gains. Prior studies in orthopedic and sports rehabilitation settings-including anterior cruciate ligament reconstruction and chronic Achilles tendinopathy-have demonstrated that low-load BFR-RT can produce physiologic adaptations comparable to traditional high-load resistance training while minimizing mechanical stress on healing tissues. However, the efficacy and safety of BFR-RT during the early rehabilitation period following primary ATR repair have not been evaluated in a prospective randomized clinical trial.

This study is designed as a prospective, three-arm randomized controlled trial to evaluate whether integrating BFR-RT into postoperative ATR rehabilitation improves early muscle recovery and functional outcomes while maintaining an acceptable safety profile. Participants undergoing primary surgical repair for an acute unilateral mid-portion ATR will be randomized to one of three rehabilitation protocols: BFR-RT combined with standard physical therapy, sham BFR-RT combined with standard physical therapy, or standard physical therapy alone. The BFR intervention will be delivered using a personalized tourniquet system that determines limb occlusion pressure for each participant to standardize vascular restriction and minimize inter-individual variability in occlusion levels.

Participants will undergo standardized postoperative rehabilitation and will be followed longitudinally over a 12-month recovery period. Clinical assessments will be performed at predefined postoperative intervals to evaluate physiologic recovery of the gastrocnemius-soleus complex and patient-centered functional outcomes. Safety monitoring will include systematic documentation of potential adverse events associated with postoperative rehabilitation or vascular restriction techniques.

By evaluating the physiologic and clinical effects of patient-specific BFR-RT following surgical ATR repair, this study aims to generate evidence regarding whether low-load metabolic training can safely accelerate muscle recovery and improve functional rehabilitation outcomes in this population. Findings from this trial may inform future postoperative rehabilitation protocols and help define the role of BFR-RT as an adjunctive strategy in tendon repair recovery pathways.

03

Conditions studied

  • Achilles Tendon Rupture
  • Blood Flow Restriction Therapy
  • Achilles Tendon Repairs/Reconstructions
  • Dynamic Blood Flow Restriction

Browse trials for

Keywords

  • Achilles Tendon
  • Tendon Injuries
  • Blood Flow Restriction Training
  • Achilles Rehabilitation
  • Postoperative Physical Therapy
  • Hypoxic Muscle Recovery
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 75 years
  • Acute unilateral midportion Achilles tendon rupture
  • Primary surgical repair performed within 2 weeks of injury
  • Willingness and ability to comply with the postoperative rehabilitation protocol and follow-up schedule

Exclusion criteria

Exclusion Criteria:

  • Cognitive impairment or inability to follow study instructions
  • Planned postoperative follow-up at another institution
  • Use of fluoroquinolone antibiotics or systemic within the past 6 months
  • Previous Achilles tendon rupture in either limb
  • Simultaneous bilateral Achilles tendon rupture
  • History of venous thromboembolism (deep venous thrombosis or pulmonary embolism)
  • Diabetes mellitus
  • Reduced lower extremity function due to conditions other than Achilles tendon rupture
  • Uncontrolled hypertension
  • Peripheral vascular disease or ankle-brachial index less than 1.0
  • Chronic kidney disease or heart failure with lower extremity edema
  • Lower extremity dialysis access
  • Lower extremity thrombophlebitis
  • Active cancer or ongoing chemotherapy treatment
  • Prior lymphadenectomy
  • Tumor or affecting the lower extremities
  • Hemophilia or other major bleeding disorders
  • Factor V Leiden mutation or known thrombophilia
  • Sickle cell anemia
  • Pregnancy
  • Surgery within the previous month
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Blood Flow Restriction Resistance Training + Standard Physical Therapy

    Participants receive standard postoperative Achilles tendon rehabilitation combined with blood flow restriction resistance training using the Delfi Personalized Tourniquet System. Cuffs are calibrated to 80% limb occlusion pressure to induce controlled vascular restriction during low-load resistance exercises. All sessions are supervised by trained physiotherapists following the standardized Massachusetts General Hospital Achilles rehabilitation protocol.

    Device: Blood Flow Restriction Resistance Training (BFR-RT) · Behavioral: Standard Physical Therapy

  • Sham comparator
    Sham Blood Flow Restriction + Standard Physical Therapy

    Participants receive the same standardized postoperative rehabilitation protocol while wearing Delfi tourniquet cuffs inflated to 20 mmHg, a pressure insufficient to induce blood flow restriction. This sham condition controls for potential placebo effects associated with the device while maintaining identical exercise protocols and therapist supervision.

    Device: Sham Blood Flow Restriction · Behavioral: Standard Physical Therapy

  • Active comparator
    Standard Physical Therapy Alone

    Participants undergo the standardized Massachusetts General Hospital postoperative Achilles tendon rehabilitation program including range-of-motion exercises, progressive strengthening, and return-to-sport phases. No blood flow restriction device is used during rehabilitation sessions.

    Behavioral: Standard Physical Therapy

Interventions

  • DeviceBlood Flow Restriction Resistance Training (BFR-RT)

    Blood flow restriction resistance training will be performed using the Delfi Personalized Tourniquet System applied to the affected limb during supervised rehabilitation exercises. The device automatically determines limb occlusion pressure (LOP) and applies 80% of LOP during low-load resistance exercises. This controlled vascular restriction produces metabolic stress intended to stimulate muscle hypertrophy and strength recovery while minimizing mechanical load on the healing Achilles tendon. Sessions are conducted under physiotherapist supervision within the standardized postoperative rehabilitation protocol.

    Also known as: Delfi Personalized Tourniquet System

  • DeviceSham Blood Flow Restriction

    Participants assigned to the sham group will wear the Delfi tourniquet cuff during rehabilitation sessions; however, cuff pressure will be inflated only to 20 mmHg, a level insufficient to induce vascular occlusion. This condition mimics the experience of the intervention device while avoiding physiologic blood flow restriction, thereby controlling for potential placebo effects associated with device use.

  • BehavioralStandard Physical Therapy

    Participants will undergo the standardized postoperative Achilles tendon rehabilitation program used at Massachusetts General Hospital. The protocol includes progressive weight-bearing, range-of-motion exercises, strengthening maneuvers, and return-to-sport progression phases supervised by trained physiotherapists.

    Also known as: Standard Postoperative Achilles Rehabilitation Protocol

06

What researchers measure

Primary outcomes

  1. Achilles Tendon Total Rupture Score (ATRS)

    The Achilles Tendon Total Rupture Score (ATRS) is a validated patient-reported outcome instrument used to assess symptoms and physical function following Achilles tendon rupture. The score ranges from 0 to 100, with higher scores indicating better function and fewer symptoms.

    Time frame: 12 months postoperatively

Secondary outcomes

  1. Ankle Plantarflexion Isometric Strength (Limb Symmetry Index)

    Isometric ankle plantarflexion strength will be measured using the Fysiometer platform. Results will be expressed as limb symmetry index (LSI), calculated as the ratio of injured limb strength to contralateral limb strength expressed as a percentage.

    Time frame: 3 months, 4.5 months, 6 months, and 12 months postoperatively

  2. Gastrocsoleus Muscle Cross-Sectional Area

    Cross-sectional area of the gastrocnemius-soleus muscle complex measured using portable ultrasound imaging to quantify muscle morphology and recovery following Achilles tendon repair.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

  3. Visual Analog Scale (VAS) Pain Score

    Pain intensity will be measured using a 10-point Visual Analog Scale (VAS), where 0 represents no pain and 10 represents the worst possible pain. Higher scores indicate greater pain severity.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

  4. Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference Score

    Pain interference will be measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference questionnaire. Scores are reported as T-scores with a mean of 50 and standard deviation of 10 in the general population; scores range from approximately 41 to 77, with higher scores indicating greater pain interference with daily activities.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

  5. Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Score

    Physical function will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function questionnaire, which evaluates the participant's ability to perform physical activities. Scores are reported as T-scores with a mean of 50 and standard deviation of 10 in the general population; higher scores indicate better physical function.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

  6. Foot and Ankle Ability Measure (FAAM)

    The Foot and Ankle Ability Measure (FAAM) is a validated patient-reported outcome instrument assessing functional limitations related to foot and ankle conditions. Scores range from 0 to 100, with higher scores indicating greater functional ability.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

  7. Single-Leg Heel Rise Test

    Functional calf endurance will be evaluated using the single-leg heel rise test measuring the number of heel raises completed on the affected limb.

    Time frame: 3 months, 4.5 months, 6 months, and 12 months postoperatively

  8. Single-Leg Heel Rise Height

    Heel rise height will be measured during the single-leg heel rise test to assess plantarflexion strength and functional calf performance.

    Time frame: 3 months, 4.5 months, 6 months, and 12 months postoperatively

  9. International Physical Activity Questionnaire - Short Form (IPAQ-SF)

    Physical activity levels will be assessed using the International Physical Activity Questionnaire - Short Form (IPAQ-SF), which evaluates participant activity levels across multiple domains.

    Time frame: 6 months and 12 months postoperatively

  10. EQ-5D-5L Quality of Life Score

    Health-related quality of life will be assessed using the EQ-5D-5L (EuroQol 5-Dimension 5-Level) questionnaire. The EQ-5D-5L index score ranges from 0 to 1, with higher scores indicating better health-related quality of life. A visual analogue scale (VAS) component ranges from 0 to 100, with higher scores indicating better self-rated health.

    Time frame: 6 months and 12 months postoperatively

  11. Ankle Range of Motion

    Active and passive ankle plantarflexion and dorsiflexion range of motion will be measured bilaterally using a goniometer.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

  12. Calf Circumference

    Bilateral calf circumference measurements will be obtained to assess muscle atrophy and recovery following Achilles tendon repair.

    Time frame: 6 weeks, 3 months, 4.5 months, 6 months, and 12 months postoperatively

Other outcomes

  1. Return-to-Sport Status and Time

    Participants will report return-to-sport status and time required to resume pre-injury sport or physical activity.

    Time frame: Up to 12 months postoperatively

07

Study locations

1 site
08

References and documents

Publications

  • O'Neill S, Weeks A, Norgaard JE, Jorgensen MG. Validity and intrarater reliability of a novel device for assessing Plantar flexor strength. PLoS One. 2023 Mar 31;18(3):e0282395. doi: 10.1371/journal.pone.0282395. eCollection 2023. PubMed 37000780 ↗
  • Callanan MC, Plummer HA, Chapman GL, Opitz TJ, Rendos NK, Anz AW. Blood Flow Restriction Training Using the Delfi System Is Associated With a Cellular Systemic Response. Arthrosc Sports Med Rehabil. 2020 Dec 27;3(1):e189-e198. doi: 10.1016/j.asmr.2020.09.009. eCollection 2021 Feb. PubMed 33615264 ↗
  • Rolnick N, Licameli N, Moghaddam M, Marquette L, Walter J, Fedorko B, Werner T. Autoregulated and Non-Autoregulated Blood Flow Restriction on Acute Arterial Stiffness. Int J Sports Med. 2024 Jan;45(1):23-32. doi: 10.1055/a-2152-0015. Epub 2023 Aug 10. PubMed 37562444 ↗
  • Hwang PS, Willoughby DS. Mechanisms Behind Blood Flow-Restricted Training and its Effect Toward Muscle Growth. J Strength Cond Res. 2019 Jul;33 Suppl 1:S167-S179. doi: 10.1519/JSC.0000000000002384. PubMed 30011262 ↗
  • Centner C, Jerger S, Lauber B, Seynnes O, Friedrich T, Lolli D, Gollhofer A, Konig D. Similar patterns of tendon regional hypertrophy after low-load blood flow restriction and high-load resistance training. Scand J Med Sci Sports. 2023 Jun;33(6):848-856. doi: 10.1111/sms.14321. Epub 2023 Feb 3. PubMed 36703264 ↗
  • Centner C, Lauber B, Seynnes OR, Jerger S, Sohnius T, Gollhofer A, Konig D. Low-load blood flow restriction training induces similar morphological and mechanical Achilles tendon adaptations compared with high-load resistance training. J Appl Physiol (1985). 2019 Dec 1;127(6):1660-1667. doi: 10.1152/japplphysiol.00602.2019. Epub 2019 Nov 14. PubMed 31725362 ↗
  • Hughes L, Rosenblatt B, Haddad F, Gissane C, McCarthy D, Clarke T, Ferris G, Dawes J, Paton B, Patterson SD. Comparing the Effectiveness of Blood Flow Restriction and Traditional Heavy Load Resistance Training in the Post-Surgery Rehabilitation of Anterior Cruciate Ligament Reconstruction Patients: A UK National Health Service Randomised Controlled Trial. Sports Med. 2019 Nov;49(11):1787-1805. doi: 10.1007/s40279-019-01137-2. PubMed 31301034 ↗
  • Hughes L, Paton B, Rosenblatt B, Gissane C, Patterson SD. Blood flow restriction training in clinical musculoskeletal rehabilitation: a systematic review and meta-analysis. Br J Sports Med. 2017 Jul;51(13):1003-1011. doi: 10.1136/bjsports-2016-097071. Epub 2017 Mar 4. PubMed 28259850 ↗
  • Eliasson P, Agergaard AS, Couppe C, Svensson R, Hoeffner R, Warming S, Warming N, Holm C, Jensen MH, Krogsgaard M, Kjaer M, Magnusson SP. The Ruptured Achilles Tendon Elongates for 6 Months After Surgical Repair Regardless of Early or Late Weightbearing in Combination With Ankle Mobilization: A Randomized Clinical Trial. Am J Sports Med. 2018 Aug;46(10):2492-2502. doi: 10.1177/0363546518781826. Epub 2018 Jul 2. PubMed 29965789 ↗
  • Heikkinen J, Lantto I, Piilonen J, Flinkkila T, Ohtonen P, Siira P, Laine V, Niinimaki J, Pajala A, Leppilahti J. Tendon Length, Calf Muscle Atrophy, and Strength Deficit After Acute Achilles Tendon Rupture: Long-Term Follow-up of Patients in a Previous Study. J Bone Joint Surg Am. 2017 Sep 20;99(18):1509-1515. doi: 10.2106/JBJS.16.01491. PubMed 28926379 ↗
  • Mashimo S, Nozaki T, Amaha K, Tanaka K, Kubota J, Sato H, Kitamura N. Quantitative Assessment of Calf Muscle Volume, Strength, and Quality After Achilles Tendon Rupture Repair: A 1-Year Prospective Follow-up Study. Am J Sports Med. 2023 Dec;51(14):3781-3789. doi: 10.1177/03635465231206391. Epub 2023 Nov 13. PubMed 37960840 ↗

Individual participant data

Plan to share: No — There are no current plans to share individual participant data. Data generated in this investigator-initiated study are subject to institutional data governance and participant privacy protections, and the study team has elected not to make IPD publicly available at this time.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.

Of 37 non-industry interventional studies with no phase under Tendon Injuries, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 46. This study's planned 10 months is below that.

Counting every sponsor, half of 39 studies reached it within 14 months; a quarter within 7 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Mar 27, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Feb 1, 2027
Last update
Apr 1, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07498166
Responsible party
Diana L. Bejarano Pineda (Foot & Ankle Orthopaedic Surgeon; Director, Minimally Invasive Foot & Ankle Surgery Assistant Professor of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital) — Principal investigator
First posted
Mar 27, 2026
Start date
Feb 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Apr 1, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion